Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2013

Open Access 01-12-2013 | Research

Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study

Authors: Alessio La Manna, Alessandra Sanfilippo, Davide Capodanno, Antonella Salemi, Alessandra Cadoni, Irene Cascone, Gesualdo Polizzi, Michele Figuera, Rosetta Pittalà, Carmelo Privitera, Corrado Tamburino

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2013

Login to get access

Abstract

Background

In patients with severe aortic stenosis, left ventricular hypertrophy is associated with increased myocardial stiffness and dysfunction linked to cardiac morbidity and mortality. We aimed at systematically investigating the degree of left ventricular mass regression and changes in left ventricular function six months after transcatheter aortic valve implantation (TAVI) by cardiovascular magnetic resonance (CMR).

Methods

Left ventricular mass indexed to body surface area (LVMi), end diastolic volume indexed to body surface area (LVEDVi), left ventricular ejection fraction (LVEF) and stroke volume (SV) were investigated by CMR before and six months after TAVI in patients with severe aortic stenosis and contraindications for surgical aortic valve replacement.

Results

Twenty-sevent patients had paired CMR at baseline and at 6-month follow-up (N=27), with a mean age of 80.7±5.2 years. LVMi decreased from 84.5±25.2 g/m2 at baseline to 69.4±18.4 g/m2 at six months follow-up (P<0.001). LVEDVi (87.2±30.1 ml /m2vs 86.4±22.3 ml/m2; P=0.84), LVEF (61.5±14.5% vs 65.1±7.2%, P=0.08) and SV (89.2±22 ml vs 94.7±26.5 ml; P=0.25) did not change significantly.

Conclusions

Based on CMR, significant left ventricular reverse remodeling occurs six months after TAVI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lorell BH, Carabello BA: Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circ. 2000, 102 (4): 470-479. 10.1161/01.CIR.102.4.470.CrossRef Lorell BH, Carabello BA: Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circ. 2000, 102 (4): 470-479. 10.1161/01.CIR.102.4.470.CrossRef
2.
go back to reference Otto CM, Bonow RO: Aortic stenosis. Braunwald’s heart disease. Edited by: Libby P, Bonow RO, Mann DL, Zipes DP. 2008, Philadelphia: WB Saunders, 1626-1628. 8 Otto CM, Bonow RO: Aortic stenosis. Braunwald’s heart disease. Edited by: Libby P, Bonow RO, Mann DL, Zipes DP. 2008, Philadelphia: WB Saunders, 1626-1628. 8
3.
go back to reference Carabello BA, Paulus WJ: Aorticstenosis. Lancet. 2009, 373: 956-966. 10.1016/S0140-6736(09)60211-7.CrossRefPubMed Carabello BA, Paulus WJ: Aorticstenosis. Lancet. 2009, 373: 956-966. 10.1016/S0140-6736(09)60211-7.CrossRefPubMed
4.
go back to reference Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD: Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003, 107: 1884-1890. 10.1161/01.CIR.0000060533.79248.0C.CrossRefPubMed Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, Yandle TG, French JK, Richards AM, White HD: Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003, 107: 1884-1890. 10.1161/01.CIR.0000060533.79248.0C.CrossRefPubMed
5.
go back to reference Otto CM: Valvular aortic stenosis: disease severity and timing of intervention. J Am CollCardiol. 2006, 47: 2141-2151. 10.1016/j.jacc.2006.03.002.CrossRef Otto CM: Valvular aortic stenosis: disease severity and timing of intervention. J Am CollCardiol. 2006, 47: 2141-2151. 10.1016/j.jacc.2006.03.002.CrossRef
6.
go back to reference Zajarias A, Cribier AG: Outcome and saphety of percutaneous valve replacement. J Am CollCardiol. 2009, 53: 1829-1836. 10.1016/j.jacc.2008.11.059.CrossRef Zajarias A, Cribier AG: Outcome and saphety of percutaneous valve replacement. J Am CollCardiol. 2009, 53: 1829-1836. 10.1016/j.jacc.2008.11.059.CrossRef
7.
go back to reference Leon MB, Smith CR, Miller DC MM, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S: PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010, 363: 1597-1607. 10.1056/NEJMoa1008232.CrossRefPubMed Leon MB, Smith CR, Miller DC MM, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S: PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010, 363: 1597-1607. 10.1056/NEJMoa1008232.CrossRefPubMed
8.
go back to reference Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP: Incidence and predictors of early and late mortality after transcatheter AorticValve implantation in 663 patients with severe aortic stenosis. Circulation. 2011, 123: 299-308. 10.1161/CIRCULATIONAHA.110.946533.CrossRefPubMed Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP: Incidence and predictors of early and late mortality after transcatheter AorticValve implantation in 663 patients with severe aortic stenosis. Circulation. 2011, 123: 299-308. 10.1161/CIRCULATIONAHA.110.946533.CrossRefPubMed
9.
go back to reference Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD: 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012, 59 (13): 1200-1254. 10.1016/j.jacc.2012.01.001.CrossRefPubMed Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD: 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012, 59 (13): 1200-1254. 10.1016/j.jacc.2012.01.001.CrossRefPubMed
10.
go back to reference Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators: Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012, 366 (18): 1686-1695. 10.1056/NEJMoa1200384.CrossRefPubMed Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators: Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012, 366 (18): 1686-1695. 10.1056/NEJMoa1200384.CrossRefPubMed
11.
go back to reference Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB: Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am CollCardiol. 2004, 43: 698-703. 10.1016/j.jacc.2003.11.026.CrossRef Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB: Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am CollCardiol. 2004, 43: 698-703. 10.1016/j.jacc.2003.11.026.CrossRef
12.
go back to reference Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am CollCardiol. 2007, 50: 69-76. 10.1016/j.jacc.2007.04.047.CrossRef Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am CollCardiol. 2007, 50: 69-76. 10.1016/j.jacc.2007.04.047.CrossRef
13.
go back to reference Ussia GP, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto AM, Immè S, Capodanno D, Sarkar K, Gulino S, Tamburino C: Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention. 2011, 7 (5): 573-579. 10.4244/EIJV7I5A93.CrossRefPubMed Ussia GP, Barbanti M, Cammalleri V, Scarabelli M, Mulè M, Aruta P, Pistritto AM, Immè S, Capodanno D, Sarkar K, Gulino S, Tamburino C: Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis. EuroIntervention. 2011, 7 (5): 573-579. 10.4244/EIJV7I5A93.CrossRefPubMed
14.
go back to reference Sherif MA, Abdel-Wahab M, Awad O, Geist V, El-Shahed G, Semmler R, Tawfik M, Khattab AA, Richardt D, Richardt G, Tölg R: Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. Am Heart J. 2010, 160 (5): 862-869. 10.1016/j.ahj.2010.07.017.CrossRefPubMed Sherif MA, Abdel-Wahab M, Awad O, Geist V, El-Shahed G, Semmler R, Tawfik M, Khattab AA, Richardt D, Richardt G, Tölg R: Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation. Am Heart J. 2010, 160 (5): 862-869. 10.1016/j.ahj.2010.07.017.CrossRefPubMed
15.
go back to reference Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A: Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010, 159 (5): 926-932. 10.1016/j.ahj.2010.02.030.CrossRefPubMed Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A: Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010, 159 (5): 926-932. 10.1016/j.ahj.2010.02.030.CrossRefPubMed
16.
go back to reference Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002, 90 (1): 29-34. 10.1016/S0002-9149(02)02381-0.CrossRefPubMed Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002, 90 (1): 29-34. 10.1016/S0002-9149(02)02381-0.CrossRefPubMed
17.
go back to reference Ahmed S, Shellock FG: Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson Imaging. 2001, 3: 171-182. 10.1081/JCMR-100107466.CrossRef Ahmed S, Shellock FG: Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson Imaging. 2001, 3: 171-182. 10.1081/JCMR-100107466.CrossRef
18.
go back to reference La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, Cincotta G, Cadoni A, Marchese A, Figuera M, Ussia GP, Pittalà R, Privitera C, Tamburino C: Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson. 2011, 13: 82-10.1186/1532-429X-13-82.PubMedCentralCrossRefPubMed La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, Cincotta G, Cadoni A, Marchese A, Figuera M, Ussia GP, Pittalà R, Privitera C, Tamburino C: Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson. 2011, 13: 82-10.1186/1532-429X-13-82.PubMedCentralCrossRefPubMed
19.
go back to reference Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ventricularsystolic and diastolic function by steady state free precession cardiovascularmagnetic resonance. J Cardiovasc Magn Reson. 2006, 8 (3): 417-426. 10.1080/10976640600572889.CrossRefPubMed Maceira AM, Prasad SK, Khan M, Pennell DJ: Normalized left ventricularsystolic and diastolic function by steady state free precession cardiovascularmagnetic resonance. J Cardiovasc Magn Reson. 2006, 8 (3): 417-426. 10.1080/10976640600572889.CrossRefPubMed
20.
go back to reference Rathod RH, Prakash A, Powell AJ, Geva T: Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am CollCardiol. 2010, 55: 1721-1728. 10.1016/j.jacc.2009.12.036.CrossRef Rathod RH, Prakash A, Powell AJ, Geva T: Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am CollCardiol. 2010, 55: 1721-1728. 10.1016/j.jacc.2009.12.036.CrossRef
21.
go back to reference Weidemann F, Herrmann S, Störk S, Niemann M, Frantz S, Lange V, Beer M, Gattenlöhner S, Voelker W, Ertl G, Strotmann JM: Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009, 120: 577-584. 10.1161/CIRCULATIONAHA.108.847772.CrossRefPubMed Weidemann F, Herrmann S, Störk S, Niemann M, Frantz S, Lange V, Beer M, Gattenlöhner S, Voelker W, Ertl G, Strotmann JM: Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009, 120: 577-584. 10.1161/CIRCULATIONAHA.108.847772.CrossRefPubMed
22.
go back to reference Ikonomidis I, Tsoukas A, Parthenakis F, Gournizakis A, Kassimatis A, Rallidis L, Nihoyannopoulos P: Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function. Heart. 2001, 86: 309-316. 10.1136/heart.86.3.309.PubMedCentralCrossRefPubMed Ikonomidis I, Tsoukas A, Parthenakis F, Gournizakis A, Kassimatis A, Rallidis L, Nihoyannopoulos P: Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function. Heart. 2001, 86: 309-316. 10.1136/heart.86.3.309.PubMedCentralCrossRefPubMed
23.
go back to reference Walther T, Falk V, Langebartels G, Krüger M, Bernhardt U, Diegeler A, Gummert J, Autschbach R, Mohr FW: Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Circulation. 1999, 100 (19 Suppl): II6-II10.PubMed Walther T, Falk V, Langebartels G, Krüger M, Bernhardt U, Diegeler A, Gummert J, Autschbach R, Mohr FW: Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy. Circulation. 1999, 100 (19 Suppl): II6-II10.PubMed
24.
go back to reference Biederman RWW, Magovern JA, Grant BS, Williams RB, Yamrozik JA, Vido DA, Rathi VK, Rayarao G, Caruppannan K, Doyle M: LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. J Cardiothorac Surg. 2011, 6: 53-10.1186/1749-8090-6-53.PubMedCentralCrossRefPubMed Biederman RWW, Magovern JA, Grant BS, Williams RB, Yamrozik JA, Vido DA, Rathi VK, Rayarao G, Caruppannan K, Doyle M: LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. J Cardiothorac Surg. 2011, 6: 53-10.1186/1749-8090-6-53.PubMedCentralCrossRefPubMed
25.
go back to reference Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE: Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol. 2002, 40 (12): 2182-88. 10.1016/S0735-1097(02)02604-9.CrossRefPubMed Lamb HJ, Beyerbacht HP, de Roos A, van der Laarse A, Vliegen HW, Leujes F, Bax JJ, van der Wall EE: Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol. 2002, 40 (12): 2182-88. 10.1016/S0735-1097(02)02604-9.CrossRefPubMed
26.
go back to reference Forsberg LM, Tamás E, Vánky F, Nielsen NE, Engvall J, Nylander E: Left and right ventricular function in aortic stenosis patients 8 weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement. Eur J Echocardiogr. 2011, 12 (8): 603-11. 10.1093/ejechocard/jer085.CrossRefPubMed Forsberg LM, Tamás E, Vánky F, Nielsen NE, Engvall J, Nylander E: Left and right ventricular function in aortic stenosis patients 8 weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement. Eur J Echocardiogr. 2011, 12 (8): 603-11. 10.1093/ejechocard/jer085.CrossRefPubMed
27.
go back to reference Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A: Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010 May, 159 (5): 926-32. 10.1016/j.ahj.2010.02.030.CrossRefPubMed Gotzmann M, Lindstaedt M, Bojara W, Mügge A, Germing A: Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010 May, 159 (5): 926-32. 10.1016/j.ahj.2010.02.030.CrossRefPubMed
28.
go back to reference Di Bello V, Giannini C, De Carlo M, Delle Donne MG, Nardi C, Palagi C, Cucco C, Dini FL, Guarracino F, Marzilli M, Petronio AS: Acute improvement in arterial-ventricular coupling after transcatheter aortic valve implantation (CoreValve) in patients with symptomatic aortic stenosis. Int J Cardiovasc Imaging. 2012, 28 (1): 79-87. 10.1007/s10554-010-9772-3.CrossRefPubMed Di Bello V, Giannini C, De Carlo M, Delle Donne MG, Nardi C, Palagi C, Cucco C, Dini FL, Guarracino F, Marzilli M, Petronio AS: Acute improvement in arterial-ventricular coupling after transcatheter aortic valve implantation (CoreValve) in patients with symptomatic aortic stenosis. Int J Cardiovasc Imaging. 2012, 28 (1): 79-87. 10.1007/s10554-010-9772-3.CrossRefPubMed
29.
go back to reference Giannini C, Petronio AS, Talini E, De Carlo M, Guarracino F, Grazia M, Donne D, Nardi C, Conte L, Barletta V, Marzilli M, Di Bello V: Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study. Am J Cardiovasc Dis. 2011, 1 (3): 264-73.PubMedCentralPubMed Giannini C, Petronio AS, Talini E, De Carlo M, Guarracino F, Grazia M, Donne D, Nardi C, Conte L, Barletta V, Marzilli M, Di Bello V: Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study. Am J Cardiovasc Dis. 2011, 1 (3): 264-73.PubMedCentralPubMed
30.
go back to reference Tzikas A, Geleijnse ML, Van Mieghem NM, Schultz CJ, Nuis RJ, van Dalen BM, Sarno G, van Domburg RT, Serruys PW, de Jaegere PP: Left ventricular mass regression one year after transcatheter aortic valve implantation. Ann Thorac Surg. 2011, 91 (3): 685-91. 10.1016/j.athoracsur.2010.09.037.CrossRefPubMed Tzikas A, Geleijnse ML, Van Mieghem NM, Schultz CJ, Nuis RJ, van Dalen BM, Sarno G, van Domburg RT, Serruys PW, de Jaegere PP: Left ventricular mass regression one year after transcatheter aortic valve implantation. Ann Thorac Surg. 2011, 91 (3): 685-91. 10.1016/j.athoracsur.2010.09.037.CrossRefPubMed
31.
go back to reference Chukwu EO, Barasch E, Mihalatos DG, Katz A, Lachmann J, Han J, Reichek N, Gopal AS: Relative importance of errors in left ventricular quantitation by two-dimensional echocardiography: insights from three-dimensional echocardiography and cardiac magnetic resonance imaging. Am Soc Echocardiogr. 2008, 21: 990-97. 10.1016/j.echo.2008.07.009.CrossRef Chukwu EO, Barasch E, Mihalatos DG, Katz A, Lachmann J, Han J, Reichek N, Gopal AS: Relative importance of errors in left ventricular quantitation by two-dimensional echocardiography: insights from three-dimensional echocardiography and cardiac magnetic resonance imaging. Am Soc Echocardiogr. 2008, 21: 990-97. 10.1016/j.echo.2008.07.009.CrossRef
32.
go back to reference Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH: Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am CollCardiol. 2011, 58 (21): 2165-73. 10.1016/j.jacc.2011.09.010.CrossRef Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH: Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am CollCardiol. 2011, 58 (21): 2165-73. 10.1016/j.jacc.2011.09.010.CrossRef
33.
go back to reference Sherif MA, Abdel-Wahab M, Beurich HW, Stöcker B, Zachow D, Geist V, Tölg R, Richardt G: Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention. 2011, 7 (1): 57-63. 10.4244/EIJV7I8A12.CrossRefPubMed Sherif MA, Abdel-Wahab M, Beurich HW, Stöcker B, Zachow D, Geist V, Tölg R, Richardt G: Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention. 2011, 7 (1): 57-63. 10.4244/EIJV7I8A12.CrossRefPubMed
34.
go back to reference Shimada YJ, Shiota T: A meta-analysis and investigation for the source of bias of left ventricular volumes and function by three-dimensional echocardiography in comparison with magnetic resonance imaging. Am J Cardiol. 2011, 107: 126-38. 10.1016/j.amjcard.2010.08.058.CrossRefPubMed Shimada YJ, Shiota T: A meta-analysis and investigation for the source of bias of left ventricular volumes and function by three-dimensional echocardiography in comparison with magnetic resonance imaging. Am J Cardiol. 2011, 107: 126-38. 10.1016/j.amjcard.2010.08.058.CrossRefPubMed
35.
go back to reference Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V: Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006, 47 (6): 1214-23. 10.1016/j.jacc.2006.01.049.CrossRefPubMed Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V: Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006, 47 (6): 1214-23. 10.1016/j.jacc.2006.01.049.CrossRefPubMed
36.
go back to reference Bové T, Van Belleghem Y, François K, Caes F, Van Overbeke H, Van Nooten G: Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcome. Eur J CardiothoracSurg. 2006, 30 (5): 706-13. 10.1016/j.ejcts.2006.07.017.CrossRef Bové T, Van Belleghem Y, François K, Caes F, Van Overbeke H, Van Nooten G: Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcome. Eur J CardiothoracSurg. 2006, 30 (5): 706-13. 10.1016/j.ejcts.2006.07.017.CrossRef
37.
go back to reference Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Lefèvre T: Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am CollCardiol. 2012, 59 (6): 566-71. 10.1016/j.jacc.2011.10.877.CrossRef Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Lefèvre T: Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am CollCardiol. 2012, 59 (6): 566-71. 10.1016/j.jacc.2011.10.877.CrossRef
38.
go back to reference Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galiñanes M: Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J. 2003, 146 (4): E13-10.1016/j.ahj.2003.09.004.CrossRefPubMed Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galiñanes M: Does the type of prosthesis influence early left ventricular mass regression after aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J. 2003, 146 (4): E13-10.1016/j.ahj.2003.09.004.CrossRefPubMed
39.
go back to reference Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC: Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. EurHeart J Cardiovasc Imaging. 2012, 13 (10): 819-26.CrossRef Flett AS, Sado DM, Quarta G, Mirabel M, Pellerin D, Herrey AS, Hausenloy DJ, Ariti C, Yap J, Kolvekar S, Taylor AM, Moon JC: Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. EurHeart J Cardiovasc Imaging. 2012, 13 (10): 819-26.CrossRef
40.
go back to reference Steadman CD, Jerosch-Herold M, Grundy B, Rafelt S, Ng LL, Squire IB, Samani NJ, McCann GP: Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc Imaging. 2012, 5 (2): 182-89. 10.1016/j.jcmg.2011.09.022.CrossRefPubMed Steadman CD, Jerosch-Herold M, Grundy B, Rafelt S, Ng LL, Squire IB, Samani NJ, McCann GP: Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc Imaging. 2012, 5 (2): 182-89. 10.1016/j.jcmg.2011.09.022.CrossRefPubMed
Metadata
Title
Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study
Authors
Alessio La Manna
Alessandra Sanfilippo
Davide Capodanno
Antonella Salemi
Alessandra Cadoni
Irene Cascone
Gesualdo Polizzi
Michele Figuera
Rosetta Pittalà
Carmelo Privitera
Corrado Tamburino
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2013
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/1532-429X-15-39

Other articles of this Issue 1/2013

Journal of Cardiovascular Magnetic Resonance 1/2013 Go to the issue